ARC China is an investment management firm based in Shanghai with an investment strategy focused on “value-oriented, activist and exit-driven equity investments”. The firm deals primarily with investments in consumption-driven, small and medium sized entrepreneur-owned enterprises in the Tier II and Tier III regions in China.

Since its inception in 2009, ARC Investment Partners has initiated and managed investments of $125mm into ten Chinese companies in Tier II, III and IV regions.

Considering themselves to be investors “off the beaten track,” ARC Investment Partners focus mainly on sustainability, consumer and healthcare sectors. These include: energy efficiency; sustainable materials; sanitation; waste water; geothermal; agriculture and forestry; branded consumer products; education; entertainment; advertising; logistics and travel; hospital management; cosmetic surgery; traditional Chinese medicine; preventive healthcare; dentistry; medical equipment and more.

ARC China has a team of more than 30 investment and due diligence professionals, with offices in Hong Kong, Shanghai, Beijing, Dalian, Chendu and Danyang, as well as offices in the U.S.